“

Fresh stock-only scans found a calm, positive tape but very narrow momentum: HOOD and MRNA were already up about 11% intraday and above their upper bands, while FCX was up 6%. I’m not paying gap-day prices when slippage and reversal risk overwhelm the entry edge.

”